Sales rise 9.71% to Rs 88.22 crore
Net profit of Astrazeneca Pharma India rose 46.16% to Rs 21.31 crore in the quarter ended June 2008 as against Rs 14.58 crore during the previous quarter ended June 2007. Sales rose 9.71% to Rs 88.22 crore in the quarter ended June 2008 as against Rs 80.41 crore during the previous quarter ended June 2007.
Spiga
INVESTMENT WORLD India's leading Financial Portal
Astrazeneca Pharma India net profit rises 46.16% in the June 2008 quarter
Tuesday, July 29, 2008 at 8:12 AM Posted by Ananth Krishna
Labels: Result corner
Subscribe to:
Post Comments (Atom)
Search
STOCK MARKET TOPIC
- Acquisition (11)
- Agri Biz and Commodities (1)
- Analysts' picks (7)
- Asian Market (3)
- Bonus (8)
- Budget-2008 (1)
- BUY BACK (2)
- Crude Oil and Gold (13)
- Dividend (80)
- Education (2)
- Europe Market (2)
- Indian Market (124)
- Industry and Economy (4)
- Investor's Guide (9)
- IPO (17)
- IPO Rating (2)
- Marc Faber Speak (2)
- Market Commentary (12)
- Movies (2)
- Order Book and Deal (67)
- Result corner (558)
- Science News (2)
- Software (2)
- Stake Sale (3)
- Stock Analysis (3)
- TAXATION (3)
- U.S. Market (48)
- Wareen buffett Speak (7)
Investor's Guide
Business News
Quotes & Stats
- All In One
- Nymex Copper
- Nymex Silver
- Nymex Gold
- Nymex Natural Gas
- Nymex Light Crude Oil
- Commodity/Currency
- European Indices
- CBOE VIX
- US After Hours
- US Pre-Market
- US Indices
- BSE Bulk Deals
- BM(Date)
- BM(Company)
- BC/RD
- NSE Heat MAP
- MF Trends
- FII Trends
- Sector Classification
- Arbitrage
- Indian GDRs
- Indian ADRs
- All Indian Quotes
- Asian Indices
Global Research
Powered byIP2Location.com
World Market Watch
Blog Archive
Business Papers
Results
Equity Analysis
Screeners
Research Reports
Technical Analysis
Misc. Links
About Me
The Link Exchange - Your ultimate resource for link exchange!
Directory
6686 links to your site!
Blogging Fusion Blog Directory
Blog Directory
Minyx v2.0 template es un theme creado por Spiga.
0 comments:
Post a Comment